Your browser doesn't support javascript.
loading
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
Molvi, Zaki; Klatt, Martin G; Dao, Tao; Urraca, Jessica; Scheinberg, David A; O'Reilly, Richard J.
Afiliação
  • Molvi Z; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA zakimolvi@gmail.com.
  • Klatt MG; Department of Hematology, Oncology and Tumor Immunology, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Dao T; German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany.
  • Urraca J; Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical 13 Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.
  • Scheinberg DA; Department of Pediatrics, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • O'Reilly RJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Immunother Cancer ; 11(9)2023 09.
Article em En | MEDLINE | ID: mdl-37775115

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfopeptídeos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfopeptídeos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article